BriaCell Therapeutics Corp. Warrant expiring 2031 Price Chart
BriaCell Therapeutics Corp. Warrant expiring 2031 Volume Chart
BriaCell Therapeutics Corp. Warrant expiring 2031 Market Segments
After Hours
*No Trades in Segment
Regular Trading Hours
-0.0301(-4.12%)
| Open | $0.7300 |
|---|---|
| Close | $0.6999 |
| Low | $0.6900 |
| Low Change | -0.0400 (-5.48%) |
| High | $0.7300 |
| High Change | +0.0000 (+0.00%) |
| Range | $0.0400 |
| Volume | 20.428K |
| Dollar Volume | $14.30K |
Premarket
*No Trades in Segment
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
-0.1100(-13.10%)
| Open | $0.8399 |
|---|---|
| Close | $0.7299 |
| Low | $0.7250 |
| Low Change | -0.1149 (-13.68%) |
| High | $0.8675 |
| High Change | +0.0276 (+3.29%) |
| Range | $0.1425 |
| Volume | 35.445K |
| Dollar Volume | $25.87K |
Premarket Yesterday
*No Trades in Segment
BriaCell Therapeutics Corp. Warrant expiring 2031 Moving Averages
| 5 Day Moving Average (SMA5) | $0.8330 |
|---|---|
| 10 Day Moving Average (SMA10) | $0.9013 |
| 20 Day Moving Average (SMA20) | $0.9492 |
| 50 Day Moving Average (SMA50) | $0.9872 |
| 100 Day Moving Average (SMA100) | — |
| 200 Day Moving Average (SMA200) | — |
BriaCell Therapeutics Corp. Warrant expiring 2031 Statistics
| Average Volume (30 Days) | 34.56K |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | 9.39 |
| Current Ratio | 10.10 |
| Quick Ratio | 10.10 |
| Debt to Equity | 0.00 |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | -0.88% |
| Return on Equity | -0.96% |
BriaCell Therapeutics Corp. Warrant expiring 2031 Stock Splits
There have been no stock splits for BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL).
BriaCell Therapeutics Corp. Warrant expiring 2031 Dividends
There have been no dividends for BriaCell Therapeutics Corp. Warrant expiring 2031 (BCTXL).